Genes related to hypertension

The term "Genes related to hypertension" refers to a broad and heterogeneous collection of genetic loci and their protein products that influence the regulation of arterial blood pressure and the development of hypertension. This category includes key components of the Renin-Angiotensin-Aldosterone System (RAAS), such as Angiotensin-Converting Enzyme (ACE) and Angiotensin II Receptor Type 1 (AGTR1), as well as various adrenergic receptors and ion channels like the L-type voltage-gated calcium channels [3][6]. Genetic variants in these genes contribute to essential hypertension by modulating vascular resistance, cardiac output, and the renal handling of salt and water [4][7]. Because this entry encompasses hundreds of distinct molecular targets—including enzymes, G protein-coupled receptors, and transporters—it is considered a categorical designation rather than a single therapeutic target [8][10]. Pharmacological management of hypertension currently utilizes diverse drug classes that target specific individual proteins within these pathways, such as ACE inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers, to reduce the risk of cardiovascular complications [1][5].

Other names

Hypertension-associated genesBlood pressure regulation genesEssential hypertension susceptibility genes

Multiple mechanisms including inhibition of the renin-angiotensin system, modulation of sympathetic nervous system activity, and regulation of ion transport to reduce peripheral resistance and blood volume.